CRYOPORT, INC. Unrealized Gain (Loss) on Derivatives and Commodity Contracts
CRYOPORT, INC. (CYRX) reported Unrealized Gain (Loss) on Derivatives and Commodity Contracts of $20.84 thousand for the 9-month period ending 2013-12-31, per its 10-Q filed 2014-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivativesAndCommodityContracts · last filed 2014-02-13
- CRYOPORT, INC. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2013-12-31 was $1.20K.
- CRYOPORT, INC. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2013-09-30 was $892.00, a 93.84% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2013-06-30 was $18.76K, a 2.99% decline year-over-year.
- CRYOPORT, INC. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2012-12-31 was -$6.11K.
| Period end | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 3 month | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 6 month | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 9 month |
|---|---|---|---|
| 2013-12-31 | $1.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | $2.09K derived: sum of 2 quarters · filed 2014-02-13 | $20.84K 10-Q · filed 2014-02-13 |
| 2013-09-30 | $892.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | $19.65K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $18.76K 10-Q · filed 2013-08-14 | ||
| 2012-12-31 | -$6.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | $8.38K derived: sum of 2 quarters · filed 2014-02-13 | $27.71K 10-Q · filed 2014-02-13 |
| 2012-09-30 | $14.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | $33.82K 10-Q · filed 2013-11-18 | |
| 2012-06-30 | $19.34K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |